She is an all-in-one trainer: part trainer, part physical therapist, part dietitian and part motivational life coach
These rules mirror Wegovy and Zepbound prescribing information
Based on analysis of employer experiences, vendor data, and expert interviews, PHTI outlines five key recommendations for employers: Establish clear, clinically driven eligibility pathways for GLP-1 coverage Require participation in behavior, nutrition, or lifestyle change programs as a condition of coverage Provide structured support for employees who choose to taper or discontinue GLP-1 therapy Review existing vendor capabilities before adding additional point solutions Contract with vendors to drive outcomes while examining overall program costs The report identifies three critical phases where these solutions can support employers in managing their GLP-1 coverage: Initiation: Providing targeted GLP-1 coverage using clinical criteria, behavioral or AI-based screening, narrow prescribing networks, or step-therapy pathways that include lower-cost alternatives or lifestyle change programs

Preparation and properties of 3-cyano pyridine ad(+), a new analogue of nad(+) [PMID: 11947468] Laboratory literature summary: Preparation and properties of 3-cyano pyridine ad(+), a new analogue of nad(+)
At PEAK, Zepbound is prescribed as part of a treatment plan that includes nutrition counseling, clinical monitoring, and ongoing support